Please do not leave this page until complete. This can take a few moments.
Branford diagnostics company Tangen Biosciences Inc. said it has closed on a $12.2 million Series B preferred stock financing, beating its fundraising target of $10 million.
Current and new investors participated in the oversubscribed round, including Connecticut Innovations, VC23, Leading Edge Ventures and Parvizi Surgical, the company said. The company previously raised $9 million in a Series A round in June 2019.
Tangen said it will use the latest money to scale up manufacturing capacity for its portable test for SARS-CoV-2, the virus that causes COVID-19.
The company received a $696,000 contract from the federal government to develop the test earlier this year, building on an earlier contract to develop a test for anthrax.
The new funding will also be used to accelerate development work on a new panel test that can detect influenza A and B, respiratory syncytial virus (RSV), and the COVID-19 virus simultaneously. That test’s release is planned for the flu season this fall.
“Once the type of respiratory disease is identified, patients can experience better clinical outcomes by having target-appropriate treatment,” President and CEO Richard Birkmeyer said in a statement.
Both tests would be used on the company’s Tangen DX and GeneSpark molecular diagnostic system, a hand-held device that can analyze results outside of a lab setting.
The company also announced the addition of two new board members, Vance Kershner and Alan Levin.
Kershner is founder, president and CEO of LabWare Inc., which develops and implements software for automating lab operations.
Levin, a former economic development director for the state of Delaware, was president and CEO of Happy Harry’s, the tenth largest drugstore chain in the U.S. before its merger with the Walgreen Company in July 2006, Tangen said.
The seven-year-old company expanded to a bigger space at 20 Commercial St. last summer. It now has 32 employees, according to New Haven Biz’s 2020 Book of Lists.
Contact Natalie Missakian at news@newhavenbiz.com
This special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
Read HereThis special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments